FTV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Fortive Corp (FTV) is not a compelling buy for a beginner investor with a long-term focus at this time. Despite some positive technical indicators and analyst upgrades, the company's recent financial performance shows significant declines in revenue and net income, and options data suggests a bearish sentiment. Additionally, the stock's forward dividend yield is low, and there are no strong catalysts to suggest immediate growth. Holding off on investment is recommended until clearer growth signals emerge.
The technical indicators show a bullish trend with MACD above zero and positively expanding, RSI in the neutral zone at 66.819, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The stock price is above the pivot level of 57.685, with resistance levels at 59.748 and 61.023. However, the stock trend analysis predicts a potential decline in the next month.
Analysts have recently raised price targets, with some firms citing better-than-expected Q4 results, strong operating performance, and potential value unlock from the Ralliant spin-off. The company also plans to expand share repurchases and accelerate organic growth in 2026.
The company's financial performance in Q4 2025 showed a significant YoY revenue drop of -30.72%, net income decline of -11.06%, and EPS decrease of -3.33%. Analysts have mixed ratings, with some expressing concerns about organic growth and demand risks in key segments. Options data suggests bearish sentiment, and the stock trend analysis predicts a potential decline in the next month.
In Q4 2025, Fortive's revenue dropped by -30.72% YoY to $1.122 billion. Net income fell by -11.06% YoY to $185.7 million, and EPS decreased by -3.33% YoY to $0.58. However, gross margin improved by 4.71% YoY to 63.15%. These results indicate challenges in revenue and profitability, despite improved margins.
Analysts have mixed ratings on Fortive. Recent upgrades include price target increases to $63-$70, with some firms highlighting strong Q4 results and potential value from the Ralliant spin-off. However, there are also concerns about organic growth, demand risks, and a slow start to 2026. Ratings range from Underweight to Buy, reflecting a divided outlook.
